Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

AD-ttorneys Law Blog

Graphic image with Transparency, Requirements, Law, Audit, Regulations, Terms, and Compliance written in hexagon shaped boxes

The View from the ANA Kids Table [ANA Children’s Advertising Recap]

It’s the Holiday Season, and the NLRB Is the Union-Friendly Gift That Keeps On Giving

Carl Hittinger Comments on Behalf of Client Alon USA Energy in Law360 Article

Preparing for the 2024 Proxy and Annual Reporting Season: Key Issues and Considerations

On June 27, 2022, Partner Lee Rosebush will speak about “The New Drug Approval Process: New Drug Research and Development,” as part of the Food and Drug Law Institute’s Introduction to Drug Law and Regulation virtual course. The audience for the course is the U.S. Army Medical Materiel Development Activity (USAMMDA), the agency within the Department of Defense that develops medical products for military service members. The course was offered to a broader audience for CLE credit in April 2022 and is being re-presented for the USAMMDA.  <a href="https://www.usammda.army.mil/index.cfm/about/about" target="_blank" rel="noopener">More about USAMMDA</a>

Lee Rosebush Offers Drug Approval Process Insights to Military Researchers

Featured Insights

Related Services

Featured Insights